Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001026336 | SCV001188697 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-12-14 | criteria provided, single submitter | clinical testing | The p.V246M variant (also known as c.736G>A), located in coding exon 8 of the RAD51D gene, results from a G to A substitution at nucleotide position 736. The valine at codon 246 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001034998 | SCV001198303 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 4 | 2022-04-06 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 246 of the RAD51D protein (p.Val246Met). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RAD51D-related conditions. ClinVar contains an entry for this variant (Variation ID: 826995). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Color Diagnostics, |
RCV001026336 | SCV001353670 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-01-08 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV002249635 | SCV002519254 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing |